Download There are some reports dealing with intravesical BCG for the

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
There are some reports dealing with intravesical BCG for the treatment of
T2 bladder cancer. See for example the paper by Volkmer et al, Journal of
Urology, 169, 931-935, March 2003. Some of the references in this paper
will also be of interest.
Intravesical chemotherapy will almost certainly be less effective than
intravesical BCG in T2 disease although there are no studies to formally
prove this. Such is the case for intermediate and high risk patients with
stage Ta and T1 disease where it has been shown that intravesical BCG is
more effective than intravesical chemotherapy. I have attached the European
Guidelines concerning this.
I will forward your e-mail to several people to see their reaction.
Sincerely yours,
Richard Sylvester
________________________________________
Richard Sylvester, ScD
Assistant Director and Head of Biostatistics
EORTC
European Organisation for Research and Treatment of Cancer
AISBL-IVZW
Avenue E. Mounierlaan, 83/11
Bruxelles 1200 Brussel
Belgique - Belgïe
Tel: +32 (0)2 7741613
Fax:+32 (0)2 7723545
E-mail: [email protected]
Website: http://www.eortc.be